TABLE OF CONTENTS

1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 DEFINITION 15
1.3 MARKET SCOPE 16
1.4 YEARS CONSIDERED FOR THE STUDY 17
1.5 CURRENCY 17
1.6 LIMITATIONS 17
1.7 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH DATA 19
2.1.1 SECONDARY DATA 20
2.1.1.1 Secondary sources 20
2.1.2 PRIMARY DATA 21
2.1.2.1 Breakdown of primaries 21
2.1.2.2 Primary sources 22
2.2 MARKET SIZE ESTIMATION 22
2.2.1 BOTTOM-UP APPROACH 23
2.2.2 TOP-DOWN APPROACH 24
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 25
2.4 ASSUMPTIONS 26
3 EXECUTIVE SUMMARY 27
4 PREMIUM INSIGHTS 31
4.1 DEFIBRILLATORS: MARKET OVERVIEW 31
4.2 REGIONAL ANALYSIS: DEFIBRILLATORS MARKET, BY PRODUCT 32
4.3 DEFIBRILLATORS MARKET, BY END USER 33
4.4 GEOGRAPHICAL SNAPSHOT OF THE DEFIBRILLATORS MARKET 33
5 MARKET OVERVIEW 34
5.1 INTRODUCTION 34
5.2 MARKET DYNAMICS 34
5.2.1 DRIVERS 35
5.2.1.1 Technological advancements in defibrillators 35
5.2.1.2 Rising prevalence of target diseases 35
5.2.1.3 Growing focus on providing public-access defibrillators 37
5.2.1.4 Training & awareness programs on defibrillators 37
5.2.2 RESTRAINTS 38
5.2.2.1 Issues related to the use of implantable and automated external defibrillators 38
5.2.3 OPPORTUNITIES 38
5.2.3.1 Emerging markets offer significant growth opportunities 38
5.2.3.2 Development of S-ICDs and MRI-compatible ICDs & CRT-Ds 39
5.2.4 CHALLENGES 40
5.2.4.1 Frequent product recalls 40
5.2.4.2 Lack of awareness about sudden cardiac arrest in developing nations 42
5.3 INDUSTRY TRENDS 42
5.3.1 INCREASING PRICING PRESSURE ON MARKET PLAYERS 42
5.3.2 GROWING NUMBER OF MERGERS AND ACQUISITIONS AMONG MARKET PLAYERS 43
5.3.3 RISING DEMAND FOR AUTOMATED EXTERNAL DEFIBRILLATORS IN PREHOSPITAL SETTINGS 43
5.4 REGULATORY SCENARIO 44
5.4.1 EXTERNAL DEFIBRILLATORS 44
5.4.2 IMPLANTABLE DEFIBRILLATORS 44
6 GLOBAL DEFIBRILLATORS MARKET, BY PRODUCT 46
6.1 INTRODUCTION 47
6.2 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS 48
6.2.1 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS 52
6.2.1.1 Biventricular ICDs/Cardiac Resynchronization Therapy Defibrillators 53
6.2.1.2 Dual-chamber ICDs 54
6.2.1.3 Single-chamber ICDs 55
6.2.2 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS 56
6.3 EXTERNAL DEFIBRILLATORS 57
6.3.1 AUTOMATED EXTERNAL DEFIBRILLATORS 60
6.3.1.1 Semi-automated External Defibrillators 61
6.3.1.2 Fully automated external defibrillators 62
6.3.2 MANUAL EXTERNAL DEFIBRILLATORS 63
6.3.3 WEARABLE CARDIOVERTER DEFIBRILLATORS 64
7 DEFIBRILLATORS MARKET, BY END USER 66
7.1 INTRODUCTION 67
7.2 HOSPITALS, CLINICS, AND CARDIAC CENTERS 67
7.3 PRE-HOSPITAL CARE SETTINGS 68
7.4 PUBLIC ACCESS MARKETS 70
7.5 HOME CARE SETTINGS 71
7.6 ALTERNATE CARE FACILITIES 72
 
8 DEFIBRILLATORS MARKET, BY REGION 74
8.1 INTRODUCTION 75
8.2 NORTH AMERICA 78
8.2.1 US 82
8.2.2 CANADA 84
8.3 EUROPE 86
8.3.1 GERMANY 90
8.3.2 UK 91
8.3.3 FRANCE 93
8.3.4 REST OF EUROPE 94
8.4 ASIA PACIFIC 96
8.4.1 JAPAN 100
8.4.2 CHINA 101
8.4.3 INDIA 103
8.4.4 REST OF ASIA PACIFIC (ROAPAC) 104
8.5 REST OF THE WORLD 106
8.5.1 LATIN AMERICA 110
8.5.2 THE MIDDLE EAST 111
8.5.3 AFRICA 113
9 COMPETITIVE LANDSCAPE 115
9.1 INTRODUCTION 115
9.2 MARKET SHARE ANALYSIS, 2016 116
9.2.1 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET: KEY PLAYERS 116
9.2.2 EXTERNAL DEFIBRILLATORS MARKET: KEY PLAYERS 117
9.3 COMPETITIVE SCENARIO 117
9.3.1 KEY PRODUCT LAUNCHES AND APPROVALS (2015-2017) 118
9.3.2 KEY AGREEMENTS, PARTNERSHIPS, CONTRACTS, AND COLLABORATIONS (2015-2017) 118
9.3.3 KEY EXPANSIONS (2015-2017) 119
9.3.4 KEY ACQUISITIONS, JOINT VENTURES, AND MERGERS (2015-2017) 119
 
10 COMPANY PROFILES 120
(Business Overview, Products & Services, Key Insights, Recent Developments, MnM View)*
10.1 MEDTRONIC 120
10.2 ST. JUDE MEDICAL 124
10.3 BOSTON SCIENTIFIC 127
10.4 PHILIPS 130
10.5 ZOLL MEDICAL 133
10.6 BIOTRONIK 136
10.7 PHYSIO-CONTROL 138
10.8 CARDIAC SCIENCE 141
10.9 LIVANOVA 145
10.10 NIHON KOHDEN 149
10.11 SCHILLER 152
10.12 MINDRAY MEDICAL 154
10.13 MEDIANA 155
10.14 METRAX 157
10.15 METSIS MEDIKAL 158
*Details on Business Overview, Products & Services, Key Insights, Recent Developments, MnM View might not be captured in case of unlisted companies.
11 APPENDIX 159
11.1 DISCUSSION GUIDE 159
11.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 164
11.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 166
11.4 AVAILABLE CUSTOMIZATIONS 168
11.5 RELATED REPORTS 168
11.6 AUTHOR DETAILS 169